Get started
Author

Soledad Iseas

Observed names: Iseas Soledad, S Iseas, S. Iseas
Observed institutions: Leiden University, Inserm, Université Paris Cité, Universidad de Buenos Aires, Leiden University Medical Center, Erasmus MC, AC Camargo Hospital, Sorbonne Université, Centre Hospitalier Universitaire de Besançon, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Institut Català d'Oncologia, Établissement Français du Sang, Laboratoire d’immunologie intégrative du cancer, Hôpital Paris Saint-Joseph, Erasmus MC Cancer Institute, Université Marie et Louis Pasteur, Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique
ORCID: 0000-0002-5401-5094
Observed ORCID: 0000-0002-5401-5094
OpenAlex ID: A5000732011
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 · Robin Kate Kelley, Makoto Ueno, et al. · The Lancet · 1,154
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
2018 · Maxime J M van der Valk, Denise E Hilling, et al. · The Lancet · 1,116
PDF
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study
2020 · Laura M Fernandez, Guilherme P São Julião, et al. · The Lancet Oncology · 214
PDF
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2020 · Carine El Sissy, Amos Kirilovsky, et al. · Clinical Cancer Research · 113
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
2023 · Sofieke J D Temmink, Koen C M J Peeters, et al. · British journal of surgery · 69
PDF
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy
2023 · Carine El Sissy, Amos Kirilovsky, et al. · Journal of Clinical Oncology · 52
PDF
Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years
2021 · Renu R Bahadoer, Koen C M J Peeters, et al. · British journal of surgery · 38
PDF
Non-surgical management of rectal cancer. Series of 68 cases, long follow up in two leading centres in Argentina
2016 · Fernando Sanchez Loria, Soledad Iseas, et al. · Digestive and Liver Disease · 36
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome
2020 · Mariano Golubicki, Laia Bonjoch, et al. · JCI Insight · 33
PDF
Lynch‐like syndrome is as frequent as Lynch syndrome in early‐onset nonfamilial nonpolyposis colorectal cancer
2019 · Marina Antelo, Mariano Golubicki, et al. · International Journal of Cancer · 30
PDF
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
2020 · Juan M. Sendoya, Soledad Iseas, et al. · Cancers · 28
PDF
A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma
2021 · Soledad Iseas, Mariano Golubicki, et al. · Translational Oncology · 25
PDF
Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review
2024 · D. Prost, S. Iseas, et al. · ESMO Open · 19
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
2022 · Isabella Kuniko T. M. Takenaka, Thais F. Bartelli, et al. · Frontiers in Oncology · 15
PDF
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection
2020 · Marcos Pedro Guedes Camandaroba, Soledad Iseas, et al. · Clinical Colorectal Cancer · 12
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
2020 · Soledad Iseas, Enrique L. Roca, et al. · Investigational New Drugs · 12
PDF
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
2024 · Soledad Iseas, Golubicki Mariano, et al. · Molecular Diagnosis & Therapy · 11
PDF
Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy
2021 · A. Pascual-Russo, D. Milito, et al. · Revista de Gastroenterología de México (English Edition) · 11
PDF
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial
2025 · Stefano Kim, Jihane Boustani, et al. · The Lancet Oncology · 9
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
2021 · Amos Kirilovsky, Carine El Sissy, et al. · Oncotarget · 9
PDF
Comprehensive Genomic Characterization of Fifteen Early-Onset Lynch-Like Syndrome Colorectal Cancers
2021 · Mariano Golubicki, Marcos Díaz-Gay, et al. · Cancers · 8
PDF
Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions
2024 · Ezequiel Lacunza, Valeria Fink, et al. · JCI Insight · 6
Influence of proton pump inhibitors on the pathological response of rectal cancer: a multicentre study
2023 · Marcelle G Cesca, Erika Ruiz-Garcia, et al. · ecancermedicalscience · 4
PDF
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort
2023 · Soledad Iseas, Diego Prost, et al. · Biomedicines · 4
PDF
TarSeqQC: Quality control on targeted sequencing experiments in R
2017 · Gabriela A. Merino, Yanina A. Murua, et al. · Human Mutation · 4
PDF
Works count: 53
Citation count: 3,042
H-index: 14
I10-index: 18
Year
Topic
Type